Viking Therapeutics Inc (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, announced yesterday that it has named Kathy Rouan, PhD as its new director.
Dr Rouan has more than 30 years of pharmaceutical industry experience and offers the company drug discovery and development expertise across a broad range of therapeutic areas including gastroenterology, cardiovascular, immune-inflammation and oncology.
Dr Rouan most recently served as senior vice president and head of Projects, Clinical Platforms and Sciences at GlaxoSmithKline (GSK). She first joined GSK in 1989 with a background in pharmaceutical sciences, focusing on formulation development of protein pharmaceuticals. In 1993, she transitioned into project leadership and management becoming vice president and head of metabolism and pulmonary project management in 1999. In 2007, Dr Rouan led the development, submission and approval of Arzerra (ofatumumab) for refractory chronic lymphocytic leukaemia. In 2012, she became head of biopharmaceutical development, assuming responsibility for delivery of GSK's portfolio of biopharmaceutical medicines. In December 2013, Dr Rouan was appointed senior vice president and head of research and development for Stiefel.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business